Z-1868-2014 Class II Terminated
FDA device recall Z-1868-2014 was initiated by Integra LifeSciences Corp. on May 19, 2014 and is designated Class II. Reason for recall: This lot of Accell Evo3C Demineralized Bone Matrix, 5cc was incorrectly packaged in boxes that describe the product as Accell Evo3 Demineralized Bone Matrix. Evo3C is contraindicated for treatment of… The recall status is terminated (terminated Sep 5, 2014). Affected quantity: 61.
Recall details
- Product Type
- Devices
- Report Date
- Jul 2, 2014
- Initiation Date
- May 19, 2014
- Termination Date
- Sep 5, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 61
Product description
Accell Evo3C Demineralized Bone Matrix, 5 cc, Model Number: 02-6000-050 , Lot Number: 132160. Product Usage: Accell Evo3c Demineralized Bone Matrix Putty is intended for filling voids and gaps in the skeletal system that are not intrinsic to the stability of the bony structure. Accell Evo3c is indicated for use as a bone graft extender in the spine, extremities and pelvis, or as a bone void filler in the extremities and pelvis. The voids or gaps may be surgically created defects or the result of traumatic injury to the bone.
Reason for recall
This lot of Accell Evo3C Demineralized Bone Matrix, 5cc was incorrectly packaged in boxes that describe the product as Accell Evo3 Demineralized Bone Matrix. Evo3C is contraindicated for treatment of vertebral compression and not indicated for use in the posterolateral spine.
Distribution pattern
US Nationwide Distribution
Code information
Model Number: 02-6000-050 , Lot Number: 132160.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1868-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026